Drawing for SANO RX

USPTO serial 85947749

SANO RX

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SETTLES LEWIS, SHAILA E
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SANO RX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gary L. Montle

GARY L. MONTLE WADDEY & PATTERSON, P.C.1600 DIVISION ST STE 500NASHVILLE, TN 37203-2774UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, namely, monitoring and diagnostics of patient drug exposure, monitoring and diagnostics of patient drug compliance, and data-driven analytics and reporting to providers of healthcare services for pharmacovigilance activities, drug dosage recommendations initial drug prescribing, and drug switchingABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 22, 2014MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Jul 22, 2014ABN5ABANDONMENT - AFTER PUBLICATION—
Jul 18, 2014EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Feb 19, 2014ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 21, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 21, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 1, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 13, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 5, 2013ALIEASSIGNED TO LIE—
Nov 8, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 17, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 16, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 16, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2013DOCKASSIGNED TO EXAMINER—
Jun 11, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 4, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance